Rank 24 • Biotech & Discovery
Recursion Pharmaceuticals
Combines experimental biology, automation, and artificial intelligence to decode biology and industrialize the drug discovery process.
Visit website- Signal Score
- 91.5
- Total raised
- $650M
- Stage
- Public
- Founded
- 2013
- Headquarters
- Salt Lake City, USA
- Region
- North America
Their signal
Recursion's highly automated wet-lab and computational pipeline, amplified by massive Nvidia partnerships and its pending Exscientia merger, solidifies its position as a frontrunner in AI-driven clinical pipelines.
Signal Score 91.5editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.